Dual DDR1 and DDR2 inhibitor 5n
Cat. No.: DC11175
Featured
Chemical Structure
2241813-33-0
We are official vendor of:
More than 5000 active chemicals with high quality for research!
Field of application
Dual DDR1 and DDR2 inhibitor 5n is a highly potent and selective small molecule inhibitor targeting both Discoidin Domain Receptor 1 (DDR1) and Discoidin Domain Receptor 2 (DDR2). These receptors are receptor tyrosine kinases (RTKs) that play critical roles in cell proliferation, migration, and extracellular matrix (ECM) remodeling. Dysregulation of DDR1 and DDR2 has been implicated in various diseases, including cancer, fibrosis, and inflammation, making them attractive therapeutic targets.
Cas No.: |
2241813-33-0 |
Chemical Name: |
3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide |
Synonyms: |
3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide;3-(2-imidazo[1,2-a]pyrazin-3-ylethynyl)-~{N}-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-propan-2-yl-benzamide;Dual DDR1 and DDR2 inhibitor 5n;DDR1/2 inhibitor 5n;GTPL10105;TQP0794;BDBM50368452;3-(2-imidazo[1,2-a]pyrazin-3-ylethynyl)-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-propan-2-ylbenzamide;FEW;N-;2241813-33-0;2241813-33-0;CHEMBL4168305;CHEMBL4168305;N-(3-(trifluoromethyl)-5-((4-methylpiperazin-1-yl)methyl)phenyl)-3-(2-(imidazo[1,2-a]pyrazin-3-yl)ethynyl)-4-isopropylbenzamide;N-(3-(trifluoromethyl)-5-((4-methylpiperazin-1-yl)methyl)phenyl)-3-(2-(imidazo[1,2-a]pyrazin-3-yl)ethynyl)-4-isopropylbenzamide;starbld0048679;starbld0048679 |
SMILES: |
FC(C1C=C(C=C(C=1)CN1CCN(C)CC1)NC(C1C=CC(=C(C#CC2=CN=C3C=NC=CN23)C=1)C(C)C)=O)(F)F |
Formula: |
C31H31F3N6O |
M.Wt: |
560.612656831741 |
Purity: |
>98% |
Sotrage: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
Dual DDR1 and DDR2 inhibitor 5n is a highly potent, selective, dual Discoidin domain receptor DDR1 and DDR2 inhibitor with Kd of 7.9 and 8.0 nM, IC50 of 9.4 and 20.4 nM, repectively; displays significant selectivity against a panel of 403 wild-type kinases at 1 uM (Abl1 IC50=494 nM); dose-dependently inhibited lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) release in mouse primary peritoneal macrophages (MPMs), attenuates lung pathophysiologic changes in LPS-challenged mice, effectively decreases the levels of TNF-α and IL-6 both in BALF and serum. |
MSDS
COA
LOT NO. |
DOWNLOAD |
|
|
2018-0101 |
|
Get Quote